1. Home
  2. DTI vs XBIT Comparison

DTI vs XBIT Comparison

Compare DTI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$1.93

Market Cap

68.0M

Sector

Industrials

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.32

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTI
XBIT
Founded
1984
2005
Country
United States
United States
Employees
432
N/A
Industry
Metal Fabrications
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.0M
74.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DTI
XBIT
Price
$1.93
$2.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
314.0K
29.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$154,446,000.00
N/A
Revenue This Year
$2.05
N/A
Revenue Next Year
$4.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.59
N/A
52 Week Low
$1.65
$2.09
52 Week High
$4.69
$3.61

Technical Indicators

Market Signals
Indicator
DTI
XBIT
Relative Strength Index (RSI) 19.17 39.52
Support Level $1.65 $2.26
Resistance Level $2.48 $2.49
Average True Range (ATR) 0.16 0.04
MACD -0.05 0.00
Stochastic Oscillator 8.94 16.67

Price Performance

Historical Comparison
DTI
XBIT

About DTI Drilling Tools International Corporation

Drilling Tools International Corp is an oilfield services company that designs, engineers, and manufactures rental-focused tools used in onshore and offshore horizontal and directional drilling operations, as well as solutions across the well life cycle. It operates through two geographic segments: Western Hemisphere and Eastern Hemisphere. The Western Hemisphere, which generates the majority of revenue, provides downhole drilling tools and rental services for onshore and offshore operations across North America and Latin America, supported by service centers in the U.S. and Canada. The Eastern Hemisphere covers Europe, the Middle East, and Asia-Pacific, where the company offers drilling and well lifecycle solutions through international service centers across the EMEA and APAC regions.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: